A detailed history of Sphera Funds Management Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 610,087 shares of KURA stock, worth $5.41 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares
610,087
Previous 610,826 0.12%
Holding current value
$5.41 Million
Previous $12.6 Million 5.21%
% of portfolio
2.19%
Previous 1.84%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $13,723 - $17,166
-739 Reduced 0.12%
610,087 $11.9 Million
Q1 2024

May 15, 2024

SELL
$13.42 - $23.53 $1.24 Million - $2.18 Million
-92,461 Reduced 13.15%
610,826 $13 Million
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $844,000 - $1.19 Million
100,000 Added 16.58%
703,287 $6.41 Million
Q1 2023

May 15, 2023

BUY
$10.71 - $14.6 $481,950 - $657,000
45,000 Added 8.06%
603,287 $7.38 Million
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $2.6 Million - $3.92 Million
-231,665 Reduced 29.33%
558,287 $6.93 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $3.55 Million - $5.74 Million
295,357 Added 59.72%
789,952 $10.8 Million
Q2 2022

Aug 15, 2022

SELL
$10.71 - $18.33 $1.32 Million - $2.27 Million
-123,649 Reduced 20.0%
494,595 $9.07 Million
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $2.52 Million - $3.63 Million
-213,994 Reduced 25.71%
618,244 $9.94 Million
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $531,606 - $851,353
43,503 Added 5.52%
832,238 $11.7 Million
Q3 2021

Nov 15, 2021

SELL
$15.42 - $21.72 $1.24 Million - $1.74 Million
-80,151 Reduced 9.22%
788,735 $14.8 Million
Q2 2021

Aug 17, 2021

BUY
$20.85 - $29.88 $3.15 Million - $4.52 Million
151,135 Added 21.06%
868,886 $18.1 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $6.09 Million - $9.64 Million
246,257 Added 52.23%
717,751 $20.3 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $3.25 Million - $4.66 Million
112,000 Added 31.15%
471,494 $15.4 Million
Q3 2020

Nov 12, 2020

SELL
$16.3 - $30.64 $2.85 Million - $5.36 Million
-175,000 Reduced 32.74%
359,494 $11 Million
Q2 2020

Aug 13, 2020

BUY
$7.95 - $18.81 $4.25 Million - $10.1 Million
534,494 New
534,494 $8.71 Million
Q3 2018

Nov 14, 2018

SELL
$16.65 - $21.85 $5.86 Million - $7.69 Million
-351,953 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$14.8 - $18.8 $324,904 - $412,716
21,953 Added 6.65%
351,953 $6.41 Million
Q1 2018

May 10, 2018

BUY
$14.5 - $23.4 $4.79 Million - $7.72 Million
330,000 New
330,000 $6.19 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $593M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.